Osteoporosis International

Article	Citations
RE: “Race/ethnic differences in trabecular bone score in mid-life women: the Study of Women’s Health Across the Nation (SWAN)”	863
Comment on “Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer”: Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget’s Disease of Bone	375
The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions	114
Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”	113
A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy)	102
Correction to: Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture pat	87
Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study	86
Mineral-rich water consumption as a non-pharmacological intervention for early menopausal bone mineral density preservation and reduction of long-term fracture risk: comment on Billington et al. Osteo	66
The effects of β-carotene on osteoporosis: a systematic review and meta-analysis of observational studies	62
The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12–19 years	57
RETRACTED ARTICLE: Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case–control study from India	54
One versus 2 years of alendronate following denosumab: the CARD extension	54
Follicle-stimulating hormone is associated with low bone mass in postmenopausal women	53
Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk	52
Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study	48
Bone mineral density assessment using radiofrequency echographic multispectrometry (REMS) in patients before and after total hip replacement	47
Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture	46
The link between osteoporosis and cardiovascular diseases: a review of shared mechanisms, risk factors, and therapeutic approaches	45
Return on investment of fracture liaison services: a systematic review and analysis	45
Epidemiology of pelvic and acetabular fractures in the USA from 2007 to 2014	44
Dual-energy x-ray absorptiometry scanner mismatch in follow-up bone mineral density testing	40
Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis	40
Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization	38
Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture	37
The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study	37

Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study	36
Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women	36
A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis	36
Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases	35
Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study	33
Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS	32
Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project	31
Artificial intelligence insights into osteoporosis: comment	30
Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nati	29
Differential fracture risk in breast cancer patients based on endocrine therapy and age: a nationwide cohort study	29
Opportunistic measures of bone mineral density at multiple skeletal sites during whole-body CT in polytrauma patients	28
Treatment patterns of romosozumab in postmenopausal women with severe osteoporosis in Denmark: findings from the ROmosozumab in Scandinavia real-world Evidence Study (ROSES)	28
Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis	28
Advantages of measuring hand grip strength in osteoporosis patients	28
Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year	27
Projected burden of femoral fracture surgeries in Japan through 2035: a nationwide population-based modeling study	27
International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures	27
Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019–2023	27
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESPRM-ESCEO-IOF Symposium Abstracts	26
Romosozumab and antiresorptive treatment: the importance of treatment sequence	26
Bisphosphonate drug holidays in osteoporosis according to fracture risk profile	26
An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family	26
Fracture liaison service evaluation during admission for fragility femur fracture increases rates of bone health intervention and outpatient follow-up	25
Correction: Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care	24
Correction to: Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China	24
Zoledronic acid–induced severe lymphopenia	24
Correction to: Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”	24
Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series	24
Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study	24
Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study	23
A randomised Phase 3 study comparing the efficacy and safety of proposed denosumab biosimilar RGB-14-P and reference denosumab in women with postmenopausal osteoporosis	23
Joint association of milk intake and blood 25(OH)D levels with fracture risk in postmenopausal women: 20-year follow-up data from the Japanese Population-Based Osteoporosis cohort study	22
Comment on: The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis	22
Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study	22
Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review	22
Proposed bone health screening protocol to identify total knee arthroplasty patients for preoperative DXA	22
Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis	22
Author response to OSIN-D-23–00510, “Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients re	22
Accelerometer-measured weekly and diurnal moderate-to-vigorous physical activity patterns and incident osteoporosis	22
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density	22
The importance of structural barriers of osteoporotic hip fracture in the elderly	22
Correction: PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis	22
Short- and long-term prognostic factors associated with functional recovery in elderly patients with hip fracture: A systematic review	22
The association of coffee consumption with the risk of osteoporosis and fractures: a systematic review and meta-analysis	22
Effects of microplastics on the bones: a comprehensive review	21
Fracture risk following bariatric surgery: a systematic review and meta-analysis	21
Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study	20
Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis	20
Insulin resistance, bone health, and fracture risk	20
Temporal trends in socioeconomic inequalities and risk of infection after hip fracture surgery: a nationwide cohort study, 2010–2021	20

Bridging the knowledge gap in rare bone disorders: insights from the APCO Asia-Pacific Rare Bone Disorders Engagement (ASPIRE) survey	20
Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population	20
Opportunistic osteoporosis screening using chest CT with artificial intelligence	20
Semi-automatic proximal humeral trabecular bone density assessment tool: technique application and clinical validation	20
The association between lumbar paraspinal muscle functional cross-sectional area on MRI and regional volumetric bone mineral density measured by quantitative computed tomography	19
Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care	19
Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review	19
Authors’ response to 01460, renal dysfunction and its influence on osteoporosis treatment outcomes: a critical review of recent findings	19
Correction to: Determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: A systematic review and meta-an	19
Letter of rebuttal to ‘Comment on: Imaging of pelvic ring fractures in older adults and its clinical implications—a systematic review’	18
Comment on “Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005–2018”	18
Impact of the COVID-19 pandemic on osteoporotic hip fractures among outpatients in Germany	18
Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.	18
Development and validation of a prediction model for falls among older people using community-based data	18
Correction: determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: a systematic review and meta-analy	18
Letter to the Editor regarding “Associations between ultra-distal forearm bone mineral density and incident fracture in women”	18
Author response to OSIN-D-24–00958 comment on: the association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis	18
Standardization of the nomenclature of bone status indices: a milestone in diagnostic consistency and clarity	18
Error in Mendelian randomization analysis in “Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma”	18
Correction to: Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study	18
Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched study	17
Prevalence of low bone mineral density (T-score ≤  − 2.5) in the whole spectrum of chronic kidney disease: a systematic review and meta-analysis	17
Efficacy and safety of romosozumab in patients with chronic kidney disease and osteoporosis: a narrative review	17
Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment	17
Mortality among older adults with osteoporotic vertebral fracture	17
Prior fragility fractures are associated with a higher risk of 8-year complications following total shoulder arthroplasty	17
Nrf2 signaling pathway: focus on oxidative stress in osteoporosis	17
Bone, cognitive, and anthropometric profiles and their relation to fracture sites in fallers: a cross-sectional study	16
A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients	16
Effects of non-supervised exercise interventions on bone mineral density in adult women: a systematic review and meta‑analysis	16
A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank	16
Anabolic-first therapy and planned sequential care in very-high-risk fracture patients: leveraging the REFRA FLS-SEIOMM signal for global implementation	16
Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study	16
Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective	16
Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment	16
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk	16
Association between osteoporosis and risk of dementia: a Korean women nationwide population-based cohort study	16
The association of frailty with clinical and economic outcomes among hospitalized older adults with hip fracture surgery	16
Editorial: Is REMS-BMD Truly a Measured Parameter? A Call for Transparency and Technical Clarification	16
Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis	16
A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients	16
A tribute to Uri A. Liberman, 1935–2022	15
RE: Clinical features of fallers and non-fallers: Finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among o	15
Comment on Byun et al.: The effect of teriparatide on fracture healing after atypical femoral fracture: a systematic review and meta-analysis	15
The effect of starting metformin on bone mineral density among women with type 2 diabetes in the Study of Women’s Health Across the Nation (SWAN)	15
Trabecular bone score in PODA, a Randomized Controlled Trial (RCT) in older African American Women	15
Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT)	15
Fragility fracture and fear of falling in middle aged adults-a prevalence study	15
Author Response to OSIN-D-24–00437: Letter to the Editor regarding “Associations between ultra-distal forearm bone mineral density and incident fracture in women”	15
Letter to the editor concerning “Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis”	15
Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study	15
Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR)	14
Opportunistic use of lumbar computed tomography and magnetic resonance imaging for osteoporosis screening	14
Prognosis and institutionalization of frail community-dwelling older patients following a proximal femoral fracture: a multicenter retrospective cohort study	14
Delayed and significant hypercalcaemia due to teriparatide therapy: a case report and review	14
Prediabetes and insulin resistance are associated with lower trabecular bone score (TBS): cross-sectional results from the Study of Women’s Health Across the Nation TBS Study	14
Femur geometry influences atypical femoral fracture location	14
Rheumatoid arthritis and osteogenesis imperfecta: is there a genetic causal association?	14
Milk intake and hip fracture incidence in community-dwelling old Icelandic adults	14
Fracture risks in patients aged 50 years and older with panhypopituitarism: a nationwide cohort study	14
Birth weight and birth length affect future fracture risk differently in men and women	14
Prolonged hypercalcemia induced by teriparatide: a case report and literature review	14
Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture	14
The high-risk hip fracture patient and the palliative care consult	14
Effects of different exercise intensity on bone mineral density in adults: a comparative systematic review and meta-analysis	13
Incidence of hip fractures in Mexico 2006–2019: increasing numbers but decreasing rates	13
Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement	13
Metabolic factors associated with incident fracture among older adults with type 2 diabetes mellitus: a nested case–control study	13
Demographics and medical burden of osteogenesis imperfecta: a nationwide database analysis	13
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthrit	13
Author response to: OSIN-D-24–00381, artificial intelligence insights into osteoporosis	13
Osteoporosis in older patients with idiopathic normal pressure hydrocephalus	13
Focal dermal hypoplasia: a probable underrecognized low bone mass disorder secondary to aberrant Wnt signaling	13
Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41	13
Lower limb bone geometry in adult individuals with X-linked hypophosphatemia: an observational study	13
Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group	13
Atypical periprosthetic femoral fracture with stem breakage: a case report	13
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trial	13
The hip fracture incidence in the high-risk area Oslo continues to decline	13
The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture—results of a large observational cohort study	13

Performance of FRAX in older adults with frailty: the Framingham Heart Study	12
The Capture the Fracture® Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit	12
CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis	12
Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis	12
The Geriatrics at Risk Score (GeRi-Score) for mortality prediction in geriatric patients with proximal femur fracture – a development and validation study from the Registry for Geriatric Trauma (ATR-D	12
Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis	12
B vitamins and bone health: a meta-analysis with trial sequential analysis of randomized controlled trials	12
Trends in serum phosphate, calcium, and parathyroid hormone levels according to renal function following denosumab	12
Exploratory use of romosozumab for osteoporosis in a patient with Hajdu–Cheney syndrome: a case report	12
Effects of combined protein and exercise interventions on bone health in middle-aged and older adults — A systematic literature review and meta-analysis of randomized controlled trials	12
Patients’ preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study	12
Commentary on the Broader Perspectives of Hip Fractures in Primary Aldosteronism: From Medical to Social	11
Standardized 25(OH)D and fall risk: overcoming challenges and enhancing clinical applications	11
Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report	11
Denosumab-associated symptomatic hypophosphatemia in normal kidney function: two case reports	11
Reply to comments on “Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis”	11
Physical function and physical activity in adults with X-linked hypophosphatemia	11
Interaction between diabetes and osteoporosis: imbalance between inflammation and bone remodeling	11
Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis	11
Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report	11
Is it important to achieve physical activity recommendations at early stages of life to improve bone health?	11
Secular trend of humeral fractures incidence rates in patients ≥ 50 years requiring hospitalization: a retrospective analysis of the public health system data in Brazil from 2004 to 2013	11
Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event	11
Effect of osteoporosis medications on vascular and valvular calcification: a systematic review and meta-analysis	11
The diagnostic value of MRI-based vertebral bone quality score for osteoporosis or osteopenia in patients undergoing lumbar surgery: a meta-analysis	11
Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews	11
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis	11
Vitamin B6 challenge as a tool for detecting ALPL mutations and diagnosing hypophosphatasia	11
Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case–control study	11
DXA-based bone strain index in normocalcemic primary hyperparathyroidism	11
Discontinuation of denosumab in men with prostate cancer	11
The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose	11
Opportunistic assessment of osteoporosis using hip and pelvic X-rays with OsteoSight™: validation of an AI-based tool in a US population	11
Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis	10
Appropriate dosing of burosumab in tumor-induced osteomalacia	10
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Plenary Lecture Abstracts	10
Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up	10
An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures	10
Magnesium exposure increases hip fracture risks in patients with chronic kidney disease: a population-based nested case–control study	10
Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020	10
Systematic review and meta-analysis of preoperative predictors for early mortality following hip fracture surgery	10
The imminent risk of a fracture—existing worldwide data: a systematic review and meta-analysis	10
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment	10
FREM predicts 10-year incident fracture risk independent of FRAX® probability: a registry-based cohort study	10
Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK	10
Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique	10
Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry	10
Bridging the gap: enhancing osteoporosis management through AI-driven predictive models	10
Management of osteoporosis in patients with chronic kidney disease	10
Association of atypical femoral fracture location and lower limb mechanical axis: a computed tomography-based finite element analysis	10
IOF position on scientists and societies operating in conflict zones	10
Development of a novel method to measure bone marrow fat fraction in older women using high-resolution peripheral quantitative computed tomography	10
Gender differences in osteoporosis	10
Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture	10
Association between total and animal proteins with risk of fracture: A systematic review and dose–response meta-analysis of cohort studies	9
Author response to: OSIN-D-25–00317, “Comment on: The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population”	9
Longitudinal assessment of physical function in adults with X-linked hypophosphatemia following initiation of burosumab therapy	9
Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005–2018	9
The clinician’s guide to prevention and treatment of osteoporosis	9
Pubertal increment in insulin resistance is negatively related to lumbar bone mineral density in 18-year-old males	9
A systematic review and meta-analysis of sequential treatment strategies for osteoporosis	9
Fragility fracture patients with a history of prior fractures more likely to present with multiple risk factors: findings from a province-wide fracture liaison service	9
Pharmacist interventions in osteoporosis management: a systematic review	9
IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference : Poster Abstracts	9
Impact of a national reimbursement policy on anti-osteoporosis medication prescription at discharge after hip-fracture surgery in Japan: an interrupted time-series analysis	9
Effect of yoga on balance, falls, and bone metabolism: a systematic review of randomized controlled trials in healthy individuals	9
Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX	9
Adjusting conventional FRAX estimates of fracture probability according to the number of prior fractures	9
Protein intake and bone health: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society	9
The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population	9
Addressing the global burden of vitamin D deficiency: insights, challenges, and the need for personalized supplementation	9
Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness–adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-labe	9
Diagnostic performance of radiomics for predicting osteoporosis in adults: a systematic review and meta-analysis	9
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis	9
Selection for treatment of patients at high risk of fracture by the short versus long term prediction models — data from the Belgian FRISBEE cohort	9
Osteoporosis and the long-term risk of peripheral artery disease: a population-based longitudinal follow-up study in Taiwan	8
Promising diagnostic performance of CBCT-based TOMOSTEOp algorithm in osteoporosis: toward a complementary populational screening tool managed by dentists?	8
Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and fragility fractures in people aged 50 years and above: retrospective cohort study using UK primary care data	8
Correction to: Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review	8
The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis	8
Total knee arthroplasty and periprosthetic distal femoral fracture: looking beyond the osteoporosis to previous osteoporotic fracture	8
Osteoporosis is not associated with increased reoperation or fracture risk three years after total ankle arthroplasty: a retrospective cohort study	8
Zoledronic acid-induced acute psychiatric disorder	8
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): SICOT-ESCEO-IOF Symposium Abstracts	8
Comments on “Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up”	8
Trends in hip fracture rates in US male veterans	8
Prevalence and risk factors of osteoporosis and fragility fractures in aging Hakka women in Taiwan	8
Weight change and the risk of hip fractures in patients with type 2 diabetes: a nationwide cohort study	8
Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture	8
Evidence-based joint statement position of perioperative bone optimization in the arthroplasty candidate, from FEMECOT, AMMOM, ACOMM, SCCOT, SECOT, SEFRAOS, SEIOMM	8
Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy:	8
Fear-avoidant beliefs and behaviours after upper limb fracture in older people: a systematic review and meta-ethnography	8
The rise and fall of raloxifene use for osteoporosis, 1999–2022	8
The significance of recent fracture location for imminent risk of hip and vertebral fractures—a nationwide cohort study on older adults in Sweden	8
Zoledronic acid after spinal cord injury mitigates losses in proximal femoral strength independent of ambulation ability	8